These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6448639)

  • 41. Inhibition of subtilisin BPN' with peptide chloromethyl ketones.
    Powers JC; Lively MO; Tippett JT
    Biochim Biophys Acta; 1977 Jan; 480(1):246-61. PubMed ID: 831835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of thrombomodulin on the kinetics of the interaction of thrombin with substrates and inhibitors.
    Hofsteenge J; Taguchi H; Stone SR
    Biochem J; 1986 Jul; 237(1):243-51. PubMed ID: 3026312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. II. Properties of thrombin derivatives as reporters of prothrombin fragment 2 binding and specificity of the labeling approach for other proteinases.
    Bock PE
    J Biol Chem; 1992 Jul; 267(21):14974-81. PubMed ID: 1634536
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trypsin-like protease from soybean seeds. Purification and some properties.
    Nishikata M
    J Biochem; 1984 Apr; 95(4):1169-77. PubMed ID: 6378896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The selective affinity labeling of factor Xa by peptides of arginine chloromethyl ketone.
    Kettner C; Shaw E
    Thromb Res; 1981 Jun 1-25; 22(5-6):645-52. PubMed ID: 7302908
    [No Abstract]   [Full Text] [Related]  

  • 46. Inhibition of fibrinolytic enzymes by thrombin inhibitors.
    Gilboa N; Villannueva GB; Fenton JW
    Enzyme; 1988; 40(2-3):144-8. PubMed ID: 2971531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inactivation of calpain I and calpain II by specificity-oriented tripeptidyl chloromethyl ketones.
    Sasaki T; Kikuchi T; Fukui I; Murachi T
    J Biochem; 1986 Jan; 99(1):173-9. PubMed ID: 3007444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparative activity of plasmin, thrombin and trypsin on chromogenic arginine-p-nitroanilides].
    Somorin O; Tokura S
    Biokhimiia; 1980 Jul; 45(7):1167-74. PubMed ID: 6260241
    [No Abstract]   [Full Text] [Related]  

  • 49. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The action of factor Xa on peptide p-nitroanilide substrates: substrate selectivity and examination of hydrolysis with different reaction conditions.
    Lottenberg R; Hall JA; Pautler E; Zupan A; Christensen U; Jackson CM
    Biochim Biophys Acta; 1986 Dec; 874(3):326-36. PubMed ID: 3790574
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inactivation of the plasminogen activator from HeLa cells by peptides of arginine chloromethyl ketone.
    Coleman P; Kettner C; Shaw E
    Biochim Biophys Acta; 1979 Jul; 569(1):41-51. PubMed ID: 111716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
    Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tosyl-lysyl chloromethane alters glucocorticoid-receptor complex nuclear binding and physical properties.
    Hubbard JR; Barrett AJ; Kalimi M
    Endocrinology; 1984 Jul; 115(1):65-72. PubMed ID: 6547389
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase.
    Renatus M; Bode W; Huber R; Stürzebecher J; Stubbs MT
    J Med Chem; 1998 Dec; 41(27):5445-56. PubMed ID: 9876114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kinetic studies of the urokinase catalysed conversion of NH2-terminal lysine plasminogen to plasmin.
    Christensen U; Müllertz S
    Biochim Biophys Acta; 1977 Jan; 480(1):275-81. PubMed ID: 137749
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhancement of catalytic activities of serine proteases by tripeptides compounds.
    Hiwasa T; Ogawa S; Kobayashi H; Ike Y
    FEBS Lett; 1996 May; 386(1):47-50. PubMed ID: 8635601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of the transformation-specific kinase in ASV-transformed cells by N-alpha-tosyl-L-lysyl chloromethyl ketone.
    Richert N; Davies PJ; Jay G; Pastan I
    Cell; 1979 Oct; 18(2):369-74. PubMed ID: 227606
    [No Abstract]   [Full Text] [Related]  

  • 58. Secretion of proteins from liver cells is suppressed by the proteinase inhibitor N-alpha-tosyl-L-lysyl chloromethane, but not by tunicamycin, an inhibitor of glycosylation.
    Edwards K; Nagashima M; Dryburgh H; Wykes A; Schreiber G
    FEBS Lett; 1979 Apr; 100(2):269-72. PubMed ID: 456565
    [No Abstract]   [Full Text] [Related]  

  • 59. Specificity of thrombin: evidence for selectivity in acylation rather than binding for p-nitrophenyl alpha-amino-p-toluate.
    Ryan TJ; Fenton JW; Chang T; Feinman RD
    Biochemistry; 1976 Mar; 15(6):1337-41. PubMed ID: 130165
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential inhibition of globin chain synthesis by tosyl-L-lysyl chloromethyl ketone.
    Mbikay M; Garrick MD
    Life Sci; 1981 Nov; 29(18):1873-9. PubMed ID: 7311721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.